Scott Norberg, D.O.

Head, Solid Tumor Cellular Therapy Group
Center for Immune-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA, United States

Disclosure information not submitted.

Presentation(s):

• PRGN-2012, a novel HPV-Targeted Immuno-Activator, induces complete and durable responses in recurrent respiratory papillomatosis patients

  Sunday, October 12, 2025
  8:12 AM - 8:18 AM EDT